Exercise testing was performed according to the Bruce protocol4 in 59% (146/249) of the patients. Data for other variables studied are available in 90% or more of patients except for left ventricular mass which was measured in 70% (174/249). Functional aerobic impairment (FAI = percent decrement from predicted maximal oxygen intake based on age, sex, and activity status) was estimated from published nomograms4 or computed. Left and right heart catheterization were performed according to standard techniques; but coronary angiography was rarely done, as was the practice during this era. For patients having more than one catheterization, the earliest study with quantitative angiographic data was used. Left heart angiograms were directly filmed in the anterior-posterior and lateral projections simultaneously at a rate of six or 12 exposures per second. Left ventricular volumes were calculated on representative supraventricular beats at least one beat removed from premature ventricular beats by the method of Dodge et al.3 The volume of valvular regurgitation was calculated as the difference between the angiographic left ventricular output (angiographic left ventricular stroke volume times heart rate) and the net forward output measured by the Fick technique prior to the angiocardiogram, as described by Sandler et al.5 Intracardiac pressures were measured with fluid-filled catheters with the mid-chest used as zero pressure. Valve orifice areas were calculated using the Figure 1 shows the survival curves for 177 surgically treated patients and 72 medically treated patients with mitral valve disease demonstrating significantly improved survival in the surgical cohort (P = 0.009). We then examined the comparability of these two cohorts for variables possibly predictive of survival. We were able to identify three diagnostic subgroups of the mitral valve disease population in which the surgical cohort appeared to have improved survival: 1) patients with mixed mitral stenosis and regurgitation, 2) patients with mitral regurgitation, and 3) mitral valve disease patients with moderate reduction in ejection fraction. Figure 2 illustrates the survival curve for patients with mixed mitral stenosis and regurgitation demonstrating improved survival (P = 0.006) for the 45 surgically treated patients compared to the 22 medically treated patients. Table 4 lists the four variables which were significantly different TIME AFTER DIAGNOSIS (YR) FIGURE 3. Actuarial survival curves of 61 surgically treated patients and 36 medically-treated patients with mitral regurgitation demonstrating improved survival of borderline significance in the surgical cohort.
SUMMARY Late follow-up (average = 7.2 years) has been obtained in 249 patients with mitral valve disease who had quantitative angiographic assessment of left ventricular function at the time of initial catheterization in the 1960s. Surgically treated patients with mitral valve disease had significantly improved survival as compared to medically treated patients with mitral disease. The subgroup with mixed mitral stenosis and regurgitation and the subgroup with moderate impairment of ejection fraction account for this improved sur-KNOWLEDGE OF PROGNOSIS in patients with valvular heart disease and, in particular, knowledge of how prognosis is altered by therapy are vital to making rational therapeutic decisions regarding these patients. Intuitively, left ventricular function would seem to be an important prognostic factor. Indeed, several studies have demonstrated that qualitative variables relating to ventricular performance such as radiographic heart size' and/or left atrial size2 are predictive of late prognosis. Quantitative angiographic measurement vival in surgically treated patients, which occurred despite greater functional and hemodynamic impairment in the surgical cohorts.
Using univariate life table survival analysis, ten variables were found to be predictive of survival in the medical cohort, and three in the surgical cohort. With multivariate Cox's regression analysis, enddiastolic volume and arteriovenous oxygen difference were significantly predictive of survival in the medical cohort; age was predictive of survival in the surgical cohort. of left ventricular volumes provides a more precise estimate of ventricular performance and may improve ability to predict survival.
Since the development of the technique of quantitative angiography at this institution over 15 years ago,3 measurement of left ventricular volumes and ejection fraction has been routine in most patients undergoing cardiac catheterization. This report details the analysis of potential prognostic indicators (including clinical, exercise, hemodynamic and angiographic variables) in 249 patients with mitral valve disease who had quantitative angiographic assessment of left ventricular performance between 1960 and 1970, and who have been followed for three to 14 years.
Methods

Patient Population
The medical records and catheterization files of all 831 adult patients having quantitative angiographic measure-ment of ejection fraction at cardiac catheterization between 1960 and 1970 inclusively at the Veterans Administration and University Hospitals were retrospectively reviewed. These patients represent approximately 45% of the total number (1843) of adult heart catheterizations done during this time for diagnostic purposes. The remainder were excluded only because quantitative angiographic data were not available. The possibility that their exclusion created a biased patient population cannot be ruled out. Seven quantitative angiographic, ten hemodynamic, three exercise, six clinical and five demographic variables were recorded from the catheterization or medical record. Each patient was categorized into one of 13 diagnostic categories according to the principal diagnosis on the catheterization form. Table 1 lists distribution by diagnosis, sex, and therapy for the 249 patients who had mitral valve disease as the primary cardiac diagnosis following the cardiac catheterization and who form the basis of this report. Of the remaining 582 patients, 205 had aortic valve disease and will form the basis of a subsequent report, 109 had multivalvular disease, and 268 had other diagnoses including cardiomyopathy, congenital lesions, and coronary disease.
Laboratory Evaluation
Exercise testing was performed according to the Bruce protocol4 in 59% (146/249) of the patients. Data for other variables studied are available in 90% or more of patients except for left ventricular mass which was measured in 70% (174/249). Functional aerobic impairment (FAI = percent decrement from predicted maximal oxygen intake based on age, sex, and activity status) was estimated from published nomograms4 or computed. Left and right heart catheterization were performed according to standard techniques; but coronary angiography was rarely done, as was the practice during this era. For patients having more than one catheterization, the earliest study with quantitative angiographic data was used. Left heart angiograms were directly filmed in the anterior-posterior and lateral projections simultaneously at a rate of six or 12 exposures per second. Left ventricular volumes were calculated on representative supraventricular beats at least one beat removed from premature ventricular beats by the method of Dodge et al. 3 The volume of valvular regurgitation was calculated as the difference between the angiographic left ventricular output (angiographic left ventricular stroke volume times heart rate) and the net forward output measured by the Fick technique prior to the angiocardiogram, as described by Sandler et al. 5 Intracardiac pressures were measured with fluid-filled catheters with the mid-chest used as zero pressure. Valve orifice areas were calculated using the Figure 1 shows the survival curves for 177 surgically treated patients and 72 medically treated patients with mitral valve disease demonstrating significantly improved survival in the surgical cohort (P = 0.009). We then examined the comparability of these two cohorts for variables possibly predictive of survival. Table 4 lists the values of the six baseline variables in which differences (P < 0.05) were observed between the two cohorts. Note that in each instance (except sex), the surgical cohort is more severely impaired. No We were able to identify three diagnostic subgroups of the mitral valve disease population in which the surgical cohort appeared to have improved survival: 1) patients with mixed mitral stenosis and regurgitation, 2) patients with mitral regurgitation, and 3) mitral valve disease patients with moderate reduction in ejection fraction. Figure 2 illustrates the survival curve for patients with mixed mitral stenosis and regurgitation demonstrating improved survival (P = 0.006) for the 45 surgically treated patients compared to the 22 medically treated patients. Table 4 lists the four variables which were significantly different TIME AFTER DIAGNOSIS (YR) FIGURE 3. Actuarial survival curves of 61 surgically treated patients and 36 medically-treated patients with mitral regurgitation demonstrating improved survival of borderline significance in the surgical cohort.
(P < 0.05) between the surgical and medical cohorts. For each of these four variables, the surgical cohort is more severely impaired. The remaining ten of the 14 baseline variables listed above were not significantly different between the two cohorts. Figure 3 demonstrates the survival curves for the patients with mitral regurgitation showing improved survival of borderline significance (P = 0.07) in the surgically treated patients. Only those variables directly reflecting the volume of regurgitation were significantly different between the medically and surgically treated cohorts, and demonstrated more severe regurgitation in the surgically treated cohort (table 4) .
Surgically-treated patients with mitral valve disease and moderate reduction in ejection fraction (31-50%) also have improved survival (P = 0.004) as shown in figure 4. shows those variables which were significantly different between the medically and surgically treated cohorts. Table 5 lists P values derived from the Mantel-HaenzelCox statistic for each of the 14 variables when survival curves are constructed for patients subgrouped according to the several levels of each variable as tabulated in table 3. Ten variables (age, arterio-venous oxygen difference, enddiastolic volume, ejection fraction, functional class, left ventricular mass, mean pulmonary artery pressure, mean pulmonary capillary pressure, severity index, and sex) are univariately predictive of survival (P < 0.05) in the medical cohort. Three of these variables (age, end-diastolic volume, and ejection fraction) were also predictive of survival in the surgical cohort. These ten variables were then examined for multivariate prediction of survival using Cox's regression analysis. In the medical cohort arterio-venous oxygen difference and end-diastolic volume were significantly predictive of survival. In the surgical cohort only age was significantly predictive of survival. Figures 5 and 6 illustrate survival curves for medically treated patients categorized by three levels of arterio-venous oxygen difference and end-diastolic volume respectively, while figure 7 illustrates survival curves for the surgical cohort categorized by age.
Prediction of Prognosis
Finally, using parameter estimates from Cox's regression analysis, five year survival for the medical (table 6) and surgical (table 7) cohorts was estimated according to equation (1) for three discrete values of age, arterio-venous oxygen difference, and end-diastolic volume. Improved probability of survival (Pr) at five years of 0.15 or more was predicted in surgically-treated patients with end-diastolic volume equal to 180 ml and at all age and arterio-venous oxygen difference levels except for normal arterio-venous oxygen difference at ages 50 and 60. Similarly, improved survival probability (Pr) 2 0.15 was seen in patients with end-diastolic volume equal to 130 ml/M2 and arterio-venous oxygen difference earlier reports of survival following mitral commissurotomy in which comparison was usually made with medically managed patients from a different time span, again showing improved survival in the more severely affected surgically treated patients. However, none of these studies presented hemodynamic data or left ventricular function data. The present study examines the survival of patients with mitral valve disease who have been carefully characterized both by hemodynamic measurements and by quantitative angiographic analysis of left ventricular function. As in any nonrandomized comparison of medical versus surgical therapy, it is possible that differences in survival between the two treatment groups are due to patient selection rather than the therapy. The more carefully characterized the patient populations are with respect to prognostic variables, the more likely it is that patient selection can be excluded (or included) as the cause of observed differences in survival. In the present study we have analyzed survival in relation to a number of important prognostic variables; an important exception is the presence or absence of coronary disease (vide infra).
The patient population reported is restricted by the requirement of technically adequate quantitative angiography. We feel that this selection of the study population is unlikely End-diastolic Volume (mu/M2) (years) (ml/100 ml) In the present series surgically-treated patients with mitral valve disease had significantly improved survival (P = 0.009) over medically treated patients ( fig. 1) Subgroup analyses have demonstrated that statistically significantly improved survival in the surgical cohort occurs primarily in patients with mixed mitral stenosis and regurgitation ( fig. 2 ; P = 0.006) and mitral valve disease patients with moderate impairment of ejection fraction ( fig. 4 ; P = 0.004), while surgically treated patients with mitral regurgitation had improved survival of borderline significance ( fig. 3 ; P = 0.07). Again, the ten variables predictive of survival (table 5) were either similar or more severely impaired in the surgically treated cohorts (table 4), except for medically treated patients with moderately reduced ejection fraction where the end-diastolic volume was larger and the ejection fraction minimally reduced compared to the surgically treated subgroup.
Before making a definitive statement that surgical therapy prolongs survival in patients with mitral valve disease, the comparability of surgically and medically treated cohorts with regard to variables known to affect survival must be ascertained. We have examined many of these variables, but have no data on the presence or absence of coronary disease, since coronary arteriography was rarely done during this era. None of these patients carried a principal diagnosis of coronary disease. Furthermore, the survival of our medical cohort is virtually idential to that of other cohorts of medically treated mitral stenosis patients,l 0-13 suggesting that these were representative patients. On the other hand, the increased proportion of males in the medical cohort may increase the likelihood of coronary artery disease in this group. Male sex is associated with decreased survival in the medical cohort (table 5) . While occult coronary disease was undoubtedly present in some of these patients, both medically and surgically treated, we believe it is unlikely to account for the large differences in survival between medically and surgically treated patients.
In the surgical cobprt, valve replacement was performed in 25% (43/171), the remainder having a reparative procedure. Current surgical practice is to perform valve replacement in most patients undergoing surgery for mitral valve disease. However, the late survival curve for patients undergoing valve replacement was parallel to that for patients undergoing reparative procedures. The only difference was the rather high operative mortality rate (28%) in patients undergoing mitral valve replacement. With currently improved surgical mortality (5-10%) for mitral valve replacement, the surgical survival curves might be moved upward magnifying further the improved survival with surgery. We believe the data confirm that surgical therapy prolongs life in patients with mitral valve disease, particularly those with mixed stenosis and regurgitation and those with moderate reduction in ejection fraction. The data also indicate reasonable probability that surgery improves survival in patients with mitral regurgitation. The survival curves for surgically treated and medically treated mitral stenosis patients were similar, but the surgically treated patients had more hemodynamic impairment. Thus, with current low operative mortality it is likely that patients with mitral stenosis experience improved survival with surgical therapy as well.
Our univariate analysis demonstrated ten variables predictive of survival in the medical cohort (table 5); but only three of these were predictive in patients with surgically treated mitral valve disease. Previous univariate studies of medically treated mitral valve disease patients have demonstrated clinical status or functional class, sex, age, atrial fibrillation, right axis deviation on electrocardiogram, and increased hilar markings to be related to survival.13' 14 Our data are consistent with these findings. In addition, we have found that four hemodynamic variables (arterio-venous oxygen difference, mean pulmonary artery pressure, mean pulmonary capillary pressure and severity index) and three quantitative angiographic variables (enddiastolic volume, ejection fraction and left ventricular mass) are also significantly predictive of survival. We are not aware of other studies relating late survival of medically treated mitral valve disease patients to hemodynamic or left ventricular function variables.
When these ten variables were examined multivariately using Cox's regression analysis, only three were found to be predictive of survival. These were arterio-venous oxygen difference and end-diastolic volume in the medical cohort, and age in the surgical cohort. The other eight variables in the medical cohort and two variables in the surgical cohort, which are predictive of survival on univariate analysis, presumably carry similar prognostic information to that given by these three variables.
Using parameter estimates from Cox's regression analysis, we have calculated five-year survival probability (Pr) for the medical and surgical cohorts for three levels of these three variables (tables 6, 7). This technique has the advantage over the univariate subgroup analysis previously presented of utilizing all the data on all the patients. From the standard error of survival probabilities (appendix), the significance of difference in survival of two subgroups can be tested. Surgical therapy appears to have the greatest beneficial effect on estimated survival probability (Pr) in mitral valve disease patients with large end-diastolic volumes and abnormal arterio-venous oxygen difference. However, due to the relatively large standard error, the estimated survival probabilities (Pr) are not statistically significantly different for medically versus surgically treated patients. Presumably, with a larger patient population, significant differences in survival probabilities (Pr) could be established for certain specified values of age, arterio-venous oxygen difference, and end-diastolic volume. A cooperative study is currently being organized to accomplish this goal. Until data from a prospective study are available, it is premature to recommend surgical therapy based on specified values of enddiastolic volume and arterio-venous oxygen difference alone.
The number of variables univariately predictive of survival are fewer in the surgical cohort (3) compared to the medical cohort (10) . Also, although end-diastolic volume and arterio-venous oxygen difference are univariately predictive of survival in the surgical cohort, the level of statistical significance is less than in the medical cohort. This is an expected finding, since successful surgery would be expected to return most of these abnormal preoperative variables toward normal. Thus, the patient who has a high pulmonary artery pressure and impaired survival without surgery, following surgery has a lower pulmonary artery pressure and improved survival. In addition, valve replacement adds a new set of variables which affect outcome and which are not related to pre-operative status such as emboli, bleeding, valve dysfunction, and valve infection.
Further prospective studies with larger numbers of patients are necessary to further define differences in survival between specific diagnoses (e.g., mitral stenosis vs. mitral regurgitation), the effect of coronary disease on survival, and the effect of lowered operative mortality on survival in the surgical cohort. Our data indicate improved survival with surgical treatment of mitral valve disease, particularly patients with mixed stenosis and regurgitation, mitral regurgitation, moderate impairment of ejection fraction, large end-diastolic volume and abnormal arterio-venous oxygen difference. The survival of patients with medically-treated mitral valve disease is poor, suggesting a need for earlier surgery. The function IC(Z,,p,G) is Hampel's influence curve of p and G, evaluated at Z. 9 20 We assume that the expansion (2) DURING HEART FAILURE in which there is a rise in left ventricular filling pressure and secondarily in mean left atrial and pulmonary artery pressures and pulmonary blood volume, hydrostatic forces account for increased pulmonary capillary filtration with extravasation of fluid into the interstitium and subsequently into the alveoli of the lung. At the same time, renal and endocrine mechanisms account for salt and water retention. Acute cardiogenic pulmonary edema (PE) has been attributed, at least in part, to retention of fluid, increases in plasma volume, and consequently increases in the preload on the heart.''3 However, acute cardiogenic pulmonary edema is associated more often with increases than decreases in hematocrit and plasma protein concentration.4' The changes would be more consistent with a decrease rather than an increase in plasma volume. In with increases in plasma volume. Hypo-oncotic edema fluid was therefore reabsorbed into the vascular compartment. The concept that acute heart failure with pulmonary edema is associated with an increase in intravascular volume is therefore not supported. To the contrary, there is a reduction of blood volume during acute pulmonary edema. During reversal of acute pulmonary edema with diuresis, there was re-expansion rather than contraction of blood volume. the present study, intravascular volumes were measured during cardiogenic pulmonary edema to quantitate plasma and total blood volumes following onset of acute pulmonary edema.
Loop diuretics have been remarkably effective for immediate management of cardiogenic pulmonary edema.6 7 However, the mechanisms by which the diuretic agents produce their favorable effects are not securely established. The most widely held concept has been that potent diuretics like furosemide re-establish cardiac competence by decreasing intravascular volume during the course of diuresis.8' 9
Preload would therefore be decreased and the effective workload on the heart would be reduced. However, in the present studies, measurements of intravascular volume after treatment with oxygen, morphine, and furosemide demonstrated an expansion rather than contraction of the intravascular volume.
Methods
Patients
Studies were performed in 21 patients, 11 men and 10 women, ranging from 44 to 83 (median 67) years in age. In 16 of the patients, PE was observed at the time of admission to the Center for the Critically Ill and in five patients, PE appeared during the course of in-patient care. Each patient presented with acute onset of respiratory distress, orthopnea, and unequivocal evidence of myocardial disease.
